VERMOX Drug Patent Profile
✉ Email this page to a colleague
When do Vermox patents expire, and what generic alternatives are available?
Vermox is a drug marketed by Janssen Pharms and is included in two NDAs.
The generic ingredient in VERMOX is mebendazole. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mebendazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERMOX?
- What are the global sales for VERMOX?
- What is Average Wholesale Price for VERMOX?
Summary for VERMOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 142 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,569 |
| What excipients (inactive ingredients) are in VERMOX? | VERMOX excipients list |
| DailyMed Link: | VERMOX at DailyMed |
Recent Clinical Trials for VERMOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| RDD Pharma Ltd | Phase 2 |
| HopeXchange Medical Center, Ghana | Phase 4 |
| Noguchi Memorial Institute for Medical Research | Phase 4 |
Pharmacology for VERMOX
| Drug Class | Anthelmintic |
US Patents and Regulatory Information for VERMOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 017481-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 208398-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VERMOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 017481-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VERMOX
See the table below for patents covering VERMOX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 2029637 | METHYL-N-5 (6)-ACYL-2-BENZIMIDAZOLYLCARBAMATE | ⤷ Sign Up |
| Italy | 1035027 | PROCEDIMENTO PER LA PREPARAZIONE DI CARBAMMATI BENZIMIDAZOLICI UTILI PER LA LORO ATTIVITA ANTI ELMINTICA E PRODOTTO RELATIVO | ⤷ Sign Up |
| Sweden | 366045 | ⤷ Sign Up | |
| Austria | 302358 | ⤷ Sign Up | |
| Spain | 380579 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
